Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 11/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9826107 | 1.00 | TBXAS1 (0.48) | TBXAS1CYP19A1CYP11B1CYP11B2NR4A2 | |
| SCHEMBL9826120 | 1.00 | TBXAS1 (0.48) | TBXAS1CYP19A1CYP11B1CYP11B2NR4A2 | |
| SCHEMBL9826272 | 0.89 | TBXAS1 (0.61) | TBXAS1CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL9826268 | 0.89 | TBXAS1 (0.61) | TBXAS1CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL9826263 | 0.89 | TBXAS1 (0.61) | TBXAS1CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL9826161 | 0.88 | TBXAS1 (0.54) | TBXAS1CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL9826172 | 0.88 | TBXAS1 (0.54) | TBXAS1CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL9826568 | 0.88 | TBXAS1 (0.54) | TBXAS1CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL9826298 | 0.80 | TBXAS1 (0.54) | TBXAS1CYP19A1 | |
| SCHEMBL9826293 | 0.80 | TBXAS1 (0.54) | TBXAS1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0150892-B1 | SUBSTITUTED ALKYLIDENE IMIDAZOLES | G.D. Searle & Co. (US) | 1991-04-24 | — | — | EP | disclosed |